Your browser doesn't support javascript.
loading
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.
Pietrantonio, F; Di Nicolantonio, F; Schrock, A B; Lee, J; Morano, F; Fucà, G; Nikolinakos, P; Drilon, A; Hechtman, J F; Christiansen, J; Gowen, K; Frampton, G M; Gasparini, P; Rossini, D; Gigliotti, C; Kim, S T; Prisciandaro, M; Hodgson, J; Zaniboni, A; Chiu, V K; Milione, M; Patel, R; Miller, V; Bardelli, A; Novara, L; Wang, L; Pupa, S M; Sozzi, G; Ross, J; Di Bartolomeo, M; Bertotti, A; Ali, S; Trusolino, L; Falcone, A; de Braud, F; Cremolini, C.
Afiliación
  • Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
  • Di Nicolantonio F; Department of Oncology, University of Torino, Candiolo, Italy; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Schrock AB; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Lee J; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Fucà G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Nikolinakos P; Medical Oncology, University Cancer & Blood Center, Athens.
  • Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Hechtman JF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Christiansen J; Department of Diagnostics, Ignyta, Inc., San Diego, USA.
  • Gowen K; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Frampton GM; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Gasparini P; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rossini D; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Gigliotti C; Department of Oncology, University of Torino, Candiolo, Italy; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Kim ST; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Hodgson J; Medical Oncology, University Cancer & Blood Center, Athens.
  • Zaniboni A; Department of Medical Oncology, Fondazione Poliambulanza, Brescia, Italy.
  • Chiu VK; Department of Internal Medicine, University of New Mexico, Albuquerque, USA.
  • Milione M; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Patel R; Department of Diagnostics, Ignyta, Inc., San Diego, USA.
  • Miller V; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Bardelli A; Department of Oncology, University of Torino, Candiolo, Italy; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Novara L; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Wang L; Department of Pathology, St Jude Children's Research Hospital, Memphis, USA.
  • Pupa SM; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Sozzi G; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ross J; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Di Bartolomeo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bertotti A; Department of Oncology, University of Torino, Candiolo, Italy; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Ali S; Clinical Development, Foundation Medicine, Inc., Cambridge, USA.
  • Trusolino L; Department of Oncology, University of Torino, Candiolo, Italy; ECMO, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Falcone A; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Ann Oncol ; 29(6): 1394-1401, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29538669
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Reordenamiento Génico / Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas c-ret Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Reordenamiento Génico / Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas c-ret Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article